contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


amniotics-to-present-cognistem-results-at-international-stem-cell-symposium

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Amniotics udvikler og producerer stamcelleterapier i deres eget GMP-certificerede anlæg. Amniotics blev født ud af opdagelsen af ​​en ny kilde til stamceller i fuldtids fostervand. Baseret på ti års forskning ved det internationalt anerkendte Lund University Stamcelle Center og Hospital, er virksomheden banebrydende inden for høst og formering af vævsspecifikke neonatale kvalitet mesenchymale stamceller (MSC).

Virksomheden er noteret på Nasdaq First North Growth Market i Stockholm.

Amniotics

Amniotics AB (publ) (Nasdaq Stockholm: AMNI) announces today that the company will present results from the development project CogniStem at Cold Spring Harbor Laboratory (CSHL) Symposium on...

<div class="mfn-preamble"><p><strong>Amniotics AB (publ) (Nasdaq Stockholm: AMNI) announces today that the company will present results from the development project CogniStem at Cold Spring Harbor Laboratory (CSHL) Symposium on Quantitative Biology focused on stem cells.</strong></p></div><div class="mfn-body"><p>The stem cell symposium is arranged by Cold Spring Harbor Laboratory (CSHL) at Long Island, and will take place May 31 - June 4, 2023.</p><p>Amit Saxena, PhD, will present the results of Amniotics mesenchymal stem cell project CogniStem.</p></div><div class="mfn-footer mfn-4a48b0e875c7"><p><strong class="mfn-heading-1">About CogniStem™</strong></p><hr><p>CogniStem is a neuro specific stem cell product of neonatal origin, derived from full-term amniotic fluid. CogniStem is expected to be efficacious in various central nervous system (CNS) diseases through modulation of the immune response and by supporting the recovery process.</p></div><div class="mfn-footer mfn-aafd572f474a"><p><strong class="mfn-heading-1">For more information please contact</strong></p><hr><p>Marcus Larsson<br>CEO, Amniotics AB<br>Phone: +46 (0) 763 0840 91<br>Email:&nbsp;<a rel="noopener" href="mailto:ml@amniotics.com">ml@amniotics.com</a></p></div><div class="mfn-footer mfn-793797edb90a"><p><strong class="mfn-heading-1">About Amnioitics</strong></p><hr><p>Amniotics AB (publ) is a clinical stage biotech company, developing innovative therapies, based on amniotic fluid derived stem cells. The company develops therapies to treat diseases where effective treatments are currently lacking.<br>Amniotics has an established GMP-facility, approved and licensed by the Swedish Medical Products Agency. The company has capabilities as a Contract Development and Manufacturing Organization (CDMO) for other biotech companies.<br>Amniotics is headquartered in Lund, Sweden.<br>The company is listed at Nasdaq First North Growth Market in Stockholm. Amniotics Certified Adviser at First North is Redeye AB, e post:&nbsp;<a rel="noopener" href="mailto:certifiedadviser@redeye.se">certifiedadviser@redeye.se</a>.<br>Learn more at&nbsp;<a rel="noopener" href="http://www.amniotics.com/">www.amniotics.com</a>.&nbsp;</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/f0c77154-c6e1-4ede-aa97-389743c1e20f/amniotics-to-present-cognistem-results-at-international-stem-cell-symposium.pdf" class="mfn-generated mfn-primary">Amniotics to present CogniStem results at international stem cell symposium</a></p></div>